Drugs / HIV p17/p24:Ty-VLP
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001053 | ? → Mar 1996 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HIV p17/p24:Ty-VLP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001053 ↗ |
| Modality | Vaccine | “HIV p17/p24:Ty-VLP (virus-like particles) vaccine” NCT00001053 ↗ |
| Route | Intramuscular | “Volunteers receive HIV p17/p24:Ty-VLP vaccine or placebo by IM injection” NCT00001053 ↗ |